Targeted Oncogenesis in the Thyroid of Transgenic Mice

Hormone Research in Paediatrics

Volumn 47, Issue 4-6, 1997, Pages 137-139

  Feunteun, J ^a   Michiels, F ^a   Rochefort, P ^a   Caillou, B ^b   Talbot, M ^b   Fournes, B ^a   Mercken, L ^d   Schlumberger, M ^c   Monier, R ^a  

^a Laboratoire de Génétique Oncologique   (France)

^b Service d Histopathologie A   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d SANOFI   (France)

Author keywords

Thyroid tumors; Transgenic mice

Indexed keywords

ADENYLATE CYCLASE; THYROGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFERENCE PAPER; CYSTADENOMA; EPITHELIUM; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; ONCOGENE C H RAS; PRIORITY JOURNAL; PROMOTER REGION; THYROID CARCINOMA; TRANSGENIC MOUSE;

ADENYLATE CYCLASE; ANIMALS; CARCINOMA, PAPILLARY; CATTLE; GENES, RAS; GTP-BINDING PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; PROMOTER REGIONS (GENETICS); THYROGLOBULIN; THYROID NEOPLASMS;

EID: 0030946423     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185456     Document Type: Article

References (30)

1. Parma J, Duprez L, Van Sandc J, Cochaux P, Gervy C, Mockcl J, Dumont J, Vassart G: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas, Nature 1993:365:649-651.
2. Wvnford-Thonias D: Oncogenes and anti-oncogenes: The molecular basis of tumor behaviour, J Pathol, 1991:165:187-201.
3. Fagin JA: Genetic basis of endocrine disease 3, Molecular defccts in thyroid gland neoplasia, J Clin Endocrinol Metab 1992:75:1398-1400.
4. Grieco M, Santoro M, Berlingieri MT, Mel ilio RM, Donglii R, Bongarzonc I, Pierotti MA, Della Porta G, Fusco A, Vecchio G: PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinoma, Cell 1990: 60:557-563.
5. Greco A, Pierotti MA, Bongarzone I, Pagliar-dini S, Lanzi C, Della Porta G: 77ÌA.-T 1 is a novel oncogene formed by the fusion of TPR and TRKgenes in human papillary thyroid carcinomas, Oncogene 1992:7:237-242.
6. Miehiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury M-T, Schlumberger M, Mercken L, Monier R, Fcunteun J: Oncogenic potential of guanine nucleotide stimulatory factor « subunit in thyroid glands of transgenic mice, Proc Natl Acad Sci USA 1994:91:10488-10492.
7. Rochefort P, Caillou B, Miehiels FM, Ledent C, Talbot M, Schlumberger M, Lavelle F, Monier R, Feunteun J: Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter, Oncogene 1996:12:111-1 18.
8. Bos JL: Ras oncogene in human cancer: A review, Cancer Res 1989:49:4682-4689.
9. Lemoine NR, Mayall HS, Wyllie FS, Williams HD, Goyns M, Stringer B, Wynford-Thomas D: High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis, Oncogene 1989:4:159-164.
10. Namba II, Gutman RA, Matsuo K, Alvarez A, Fagin JA: H-ras proto-oncogene mutations in human thyroid neoplasms,.J Clin Endocrinol Metab 1990:71:223-229.
11. Suarez HG, du Villard JA, Severino M, Caillou B, Schumberger M, Tubiana M, Parmentier C, Monier R: Presence of mutations in all three ras genes in human thyroid tumors, Oncogene 1990:5:565-570.
12. Karga H, Lee JK, Vickery AL, Thor A, Gaz RD, Jameson JL: Ras oncogene mutations in benign and malignant neoplasms, J Clin Endocrinol Metab 1991:73:832-836.
13. Lemoine NR, Mayall E, Wvllic FS, Williams ED, Thurston V, Wynford-Thomas D: Agent-specific ras oncogene activation in rat thyroid tumors, Oncogene 1988:3:541-544.
14. Shi Y, Zou M, Schmidt H, Juhasz F, Slensky V, Robb D, Farid NR: High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area, Cancer Res 1991:51:2690-2693.
15. Said S, Schlumberger M, Suarez HG: Oncogenes and anti-oncogenes in human epithelial thyroid tumors, J Endocrinol Invest 1994:17: 371-379.
16. Bongarzone I, Pierotti MA, Monzini N, Mon-dellini P, Manenti G, Donghi R, Piloni S, Grieco M, Santoro M, Fusco A, Vecchio G, Della Porta G: High frequency of activation of tyrosine kinase oncogcncs in human papillary thyroid carcinoma, Oncogene 1989:4:1457-1462.
17. Santoro M, Carlomagno F, Hay ID, Hermann MA, Grieco M, Melillo R, Pierotti MA, Bongarzonc I, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB, Fusco A: Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype, J Clin Invest 1992:89:1517-1522.
18. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R: gsp mutations in human thyroid tumors, Oncogene 1991;6:677-679.
19. Wright PA, Williams ED, Lemoine NR, Wvn-ford-Thomas D: Radiation-associatcd and ‘spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation, Oncogene 1991:6:471-473.
20. Ledent C, Parmentier M, Vassart G: Tissue-specific expression and methylation of a thvro-globulin-chloramphenicoi acctyltransferase fusion gene in transgenic mice, Proc Natl Acad Sci USA 1990:87:6176-6180.
21. Dumont IE, Jauniaux J, Roger PP: The cyclic AMP-mediated stimulation of cell proliferation, Trends Biochem Sci 1989:14:67-71.
22. Dumont JF., La my F, Roger P, Maenhout C: Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors, Physiol Rev 1992:72:667-697.
23. Duprez L, Parma J, Van Sandc J, Allgeir A, Lcclere J, Schvartz C, Dclislc M, Decoulx M, Orgiazzi J, Dumont JE, Vassart G: Germline mutations in the thyrotropin receptor gene cause non-autoimmunc autosomal dominant hyperthyroidism, Nat Genet, in press.
24. Ledent C, Dumont JE, Vassart G, Parmentier M: Thyroid expression of an A: adenosine receptor transgenc induces thyroid hyperplasia and hyperthyroidism, EMBO J 1992:11:537-542
25. Weinstein LS, Shenkcr A, Gejman V, Merino MJ, Friedman E, Spiegel AM: Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med 1991:325:1688-1695.
26. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the a chain of Gs and stimulate adenvlyl cyclasc in human pituitary tumors, Nature 1989:340:692-696.
27. O’Sullivan CO, Barton CM, Staddon SL, Brown CL, Lemoine NR: Activating point mutations of the gsp oncogene in human thyroid adenomas, Mol Carcinog 1991:4:345-349.
28. Conklin BR, Bourne HR: Structural elements of Ga subunits that interact with GBG, receptors, and effectors, Cell 1993:73:631-641.
29. Hamburger JI: Solitary autonomously functioning thyroid lesions: Diagnosis, clinical features and pathogenic considerations, Am J Med 1975:58:740-748.
30. Adams JM, Cory S: Transgenic models of tumor development, Science 1991:254:1161-1167.